» Articles » PMID: 32243654

ACVIM Consensus Statement Guidelines for the Classification, Diagnosis, and Management of Cardiomyopathies in Cats

Overview
Date 2020 Apr 4
PMID 32243654
Citations 107
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiomyopathies are a heterogeneous group of myocardial disorders of mostly unknown etiology, and they occur commonly in cats. In some cats, they are well-tolerated and are associated with normal life expectancy, but in other cats they can result in congestive heart failure, arterial thromboembolism or sudden death. Cardiomyopathy classification in cats can be challenging, and in this consensus statement we outline a classification system based on cardiac structure and function (phenotype). We also introduce a staging system for cardiomyopathy that includes subdivision of cats with subclinical cardiomyopathy into those at low risk of life-threatening complications and those at higher risk. Based on the available literature, we offer recommendations for the approach to diagnosis and staging of cardiomyopathies, as well as for management at each stage.

Citing Articles

The Pathological and Histopathological Findings in Cats with Clinically Recognised Hypertrophic Cardiomyopathy Are Related to the Severity of Clinical Signs and Disease Duration.

Janus-Ziolkowska I, Bubak J, Ciaputa R, Kandefer-Gola M, Noszczyk-Nowak A Animals (Basel). 2025; 15(5).

PMID: 40075986 PMC: 11898935. DOI: 10.3390/ani15050703.


Retrospective Evaluation of Subpleural Consolidations Using Lung Ultrasound in 634 Dogs and 347 Cats.

Kraszewska K, Gajewski M, Boysen S, Buda N Animals (Basel). 2025; 15(4).

PMID: 40003031 PMC: 11851566. DOI: 10.3390/ani15040549.


Genetic counseling in veterinary medicine: towards an evidence-based definition for the small animal practice.

Adant L, Szymczak V, Bhatti S, Smets P, Saunders J, Peelman L BMC Vet Res. 2025; 21(1):89.

PMID: 39987142 PMC: 11846242. DOI: 10.1186/s12917-025-04495-4.


Subcutaneous Furosemide Therapy for Chronic Management of Refractory Congestive Heart Failure in Dogs and Cats.

Lombardo S, Ferasin H, Ferasin L Animals (Basel). 2025; 15(3).

PMID: 39943128 PMC: 11815753. DOI: 10.3390/ani15030358.


Pharmacodynamics of single-dose omecamtiv mecarbil administered intravenously in clinically healthy cats.

Ishizaka M, Hsu H, Miyagawa Y, Takemura N Open Vet J. 2025; 14(12):3614-3624.

PMID: 39927371 PMC: 11799624. DOI: 10.5455/OVJ.2024.v14.i12.42.


References
1.
Trehiou-Sechi E, Tissier R, Gouni V, Misbach C, Petit A, Balouka D . Comparative echocardiographic and clinical features of hypertrophic cardiomyopathy in 5 breeds of cats: a retrospective analysis of 344 cases (2001-2011). J Vet Intern Med. 2012; 26(3):532-41. DOI: 10.1111/j.1939-1676.2012.00906.x. View

2.
Borgeat K, Sherwood K, Payne J, Luis Fuentes V, Connolly D . Plasma cardiac troponin I concentration and cardiac death in cats with hypertrophic cardiomyopathy. J Vet Intern Med. 2014; 28(6):1731-7. PMC: 4895638. DOI: 10.1111/jvim.12459. View

3.
Henik R, Stepien R, Bortnowski H . Spectrum of M-mode echocardiographic abnormalities in 75 cats with systemic hypertension. J Am Anim Hosp Assoc. 2004; 40(5):359-63. DOI: 10.5326/0400359. View

4.
Atkins C, Gallo A, Kurzman I, Cowen P . Risk factors, clinical signs, and survival in cats with a clinical diagnosis of idiopathic hypertrophic cardiomyopathy: 74 cases (1985-1989). J Am Vet Med Assoc. 1992; 201(4):613-8. View

5.
Payne J, Brodbelt D, Luis Fuentes V . Cardiomyopathy prevalence in 780 apparently healthy cats in rehoming centres (the CatScan study). J Vet Cardiol. 2016; 17 Suppl 1:S244-57. DOI: 10.1016/j.jvc.2015.03.008. View